PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Clinical laboratory, Dalang Hospital of Dongguan City, Dongguan.\', \'Research and Development Department, Jinzhun Biological Engineering Co., Ltd. Shenzhen.\', \'Department of Clinical laboratory, People\'s Hospital of Dongguan, Dongguan.\', \'Department of Intensive Medicine, The Second Affiliated hospital of University of South China, Hengyang, China.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1097/MD.0000000000026131
?:hasPublicationType
?:journal
  • Medicine
is ?:pmid of
?:pmid
?:pmid
  • 34087864
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.105
?:rankingScore_hIndex
  • 4
?:title
  • Serum IL-6 and procalcitonin are two promising novel biomarkers for evaluating the severity of COVID-19 patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34087864>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34087864>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all